BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 8571309)

  • 41. [Classification and treatment of DIC].
    Asakura H; Saito M
    Rinsho Ketsueki; 1995 Apr; 36(4):314-9. PubMed ID: 7783336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of modified non-overt DIC criteria on the prediction of poor outcome in patients with sepsis.
    Oh D; Jang MJ; Lee SJ; Chong SY; Kang MS; Wada H
    Thromb Res; 2010 Jul; 126(1):18-23. PubMed ID: 20079919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M; López Fernández MF; Batlle J
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnosis of DIC based on evidence].
    Wada H; Nishioka J; Nobori T; Sakaguchi A; Abe Y
    Rinsho Byori; 2006 Nov; 54(11):1172-7. PubMed ID: 17240840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
    Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
    Mosad E; Elsayh KI; Eltayeb AA
    Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting the severity of systemic inflammatory response syndrome (SIRS)-associated coagulopathy with hemostatic molecular markers and vascular endothelial injury markers.
    Iba T; Gando S; Murata A; Kushimoto S; Saitoh D; Eguchi Y; Ohtomo Y; Okamoto K; Koseki K; Mayumi T; Ikeda T; Ishhikura H; Ueyama M; Ogura Y; Endo S; Shimazaki S;
    J Trauma; 2007 Nov; 63(5):1093-8. PubMed ID: 17993956
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Good or poor responses of hemostatic molecular markers in patients with hematopoietic disorders after treatment of disseminated intravascular coagulation.
    Watanabe R; Wada H; Yamamuro M; Inoue A; Watanabe M; Kumeda K; Sakakura M; Okugawa Y; Nakasaki T; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Nobori T; Shiku H
    Clin Appl Thromb Hemost; 2003 Jan; 9(1):71-7. PubMed ID: 12643327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model.
    Aoshima K; Asakura H; Yamazaki M; Saito M; Kumabashiri I; Morishita E; Ontachi Y; Mizutani T; Ichino T; Matsuda T
    Semin Thromb Hemost; 1998; 24(3):227-31. PubMed ID: 9701452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
    Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
    Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit.
    Okabayashi K; Wada H; Ohta S; Shiku H; Nobori T; Maruyama K
    Am J Hematol; 2004 Jul; 76(3):225-9. PubMed ID: 15224356
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Plasma fibrin monitor level in DIC patients with a hematopoietic malignancy].
    Hiyoyama K; Wada H; Shimura M; Deguchi H; Nagaya S; Wakita Y; Deguchi K; Shiku H
    Rinsho Byori; 1996 Jan; 44(1):57-60. PubMed ID: 8691641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases.
    Kawasugi K; Wada H; Hatada T; Okamoto K; Uchiyama T; Kushimoto S; Seki Y; Okamura T; Nobori T;
    Thromb Res; 2011 Aug; 128(2):186-90. PubMed ID: 21429565
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Fibrin monomer assay].
    Kobayashi H; Matsuo M; Ikeguchi K; Yamamoto K; Kario K; Matsuo T
    Rinsho Byori; 1991 Jul; 39(7):689-93. PubMed ID: 1920860
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on molecular markers for hemostasis and thrombosis in various renal diseases].
    Shibata T; Ishii T; Tomo T; Kaneko K; Nasu M; Magari Y; Fukushima K
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):373-8. PubMed ID: 1831516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Adequate parameters for the diagnosis of disseminated intravascular coagulation (DIC) in patients with liver diseases].
    Iwabuchi S; Takatori M; Okabe K
    Nihon Rinsho; 1993 Jan; 51(1):67-73. PubMed ID: 8381886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.
    Gando S; Kameue T; Nanzaki S; Nakanishi Y
    Thromb Haemost; 1996 Feb; 75(2):224-8. PubMed ID: 8815564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnosis and prognosis of overt disseminated intravascular coagulation in a general hospital -- meaning of the ISTH score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation.
    Cauchie P; Cauchie Ch; Boudjeltia KZ; Carlier E; Deschepper N; Govaerts D; Migaud-Fressart M; Woodhams B; Brohée D
    Am J Hematol; 2006 Jun; 81(6):414-9. PubMed ID: 16680742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.